Japan RM Seminar

Japan’s Regenerative Medicine Market:
Expedited Approval System Creates New Opportunities for Canadian Cell Therapy Companies and Researchers

JETRO and the Centre for Commercialization of Regenerative Medicine (CCRM) hosted a seminar on Japan's Regenerative Medicine Market on January 29th, 2016 at the Hilton Toronto.

In 2014, Japan introduced an expedited approval system for regenerative medicine products as well as other reforms related to the supply of stem cells.

Foreign companies and researchers are now looking at Japan as a potential location for clinical trials. There are also new business opportunities emerging for foreign companies as Japan develops its regenerative medicine related infrastructure.

Speakers at this event explained about the new expedited approval system in Japan and gave examples of on-going collaborations between Canada and Japan in the field of regenerative medicine.

January 29th, 2016
9:00 am - 12:00 pm
(registration 8:00 am)

Hilton Toronto (York Suite)
145 Richmond Street West,
Toronto, ON M5H 2L2

- Japan External Trade Organization (JETRO)
- Centre for Commercialization of Regenerative Medicine (CCRM)
Supporting Organizations:
- Ontario Institute for Regenerative Medicine (OIRM)
- International Society for Cellular Therapy (ISCT) 
Japan RM Seminar Flyer
Japan RM Seminar Agenda
8:00 – 9:00 am:
Registration / Networking
9:00 – 9:05 am:
Opening Remarks
Kazuo Nakamura, Executive Director, JETRO Toronto
9:05 – 9:20 am:
Canada and Japan: Opportunities for Increased Linkages and Cooperation in Regenerative Medicine
Dr. Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
CCRM Presentation
9:20 – 10:00 am:
Keynote Presentation: Japan’s Regenerative Medicine Market
Dr. Fusako Nishigaki, Vice Chair, Steering Committee, Forum for Innovative Regenerative Medicine (FIRM)
(Research Fellow, Research Management, Regenerative Medicine Labs, Drug Discovery Research, Astellas Pharma Inc.)
Not Available - see Japan RM Market information page instead
10:00 – 10:20 am:

10:20 – 10:40 am:
Overview of Canada-Japan Stem Cell Research Collaborations
Dr. Janet Rossant, Executive Director, Ontario Institute for Regenerative Medicine (OIRM)
OIRM Presentation
10:40 – 11:00 am:
Case-study: RepliCel and Shiseido
Mr. Lee Buckler, CEO, President & Director, Replicel Life Sciences Inc.
RepliCel Presentation
11:00 – 11:10 am:
JETRO Programmes and Services
Ms. Haruka Ogawa, Director of Business Development, JETRO Toronto
JETRO Presentation
11:10 – 11:20 am:
Closing Remarks
11:20 am – 12:00 pm:
Summary of Presentations:
Japan RM Seminar Summary

This event is over but if you would like more information on this topic, please contact JETRO Toronto:
Tyson Garbe, Assistant Director, Trade & Investment
Tel: 416-861-0000 x203
Email: Tyson_Garbe@jetro.go.jp